CSIMarket
 
Adc Therapeutics Sa  (ADCT)
Other Ticker:  
 
 
Price: $3.5700 $-0.11 -2.989%
Day's High: $3.88 Week Perf: -4.29 %
Day's Low: $ 3.37 30 Day Perf: -17.74 %
Volume (M): 837 52 Wk High: $ 6.04
Volume (M$): $ 2,988 52 Wk Avg: $2.38
Open: $3.86 52 Wk Low: $0.36



 Market Capitalization (Millions $) 295
 Shares Outstanding (Millions) 83
 Employees -
 Revenues (TTM) (Millions $) 298
 Net Income (TTM) (Millions $) -442
 Cash Flow (TTM) (Millions $) -92
 Capital Exp. (TTM) (Millions $) 4

Adc Therapeutics Sa
We are a leading global supplier of broadband network equipment, software and systems integration services that enable communications service providers to deliver high-speed Internet, data, video and voice services to consumers and businesses worldwide. Telephone companies, cable television operators, Internet and data service providers, wireless service providers and other communications service providers are building and upgrading the broadband network infrastructure required to offer high-speed Internet access as well as data, video, telephony and other interactive multimedia services. Our product offerings and development efforts are focused on increasing the speed and efficiency of the last mile/kilometer portion of broadband communications networks, and our product and service offerings help connect communications service providers' offices to businesses and end users' homes as well as to wireless communications devices. Our customers include local and long-distance telephone companies, cable television operators, wireless service providers, new competitive service providers, broadcasters, governments, businesses, system integrators and communications equipment manufacturers and distributors. We offer broadband connectivity components and systems, broadband access and network equipment, software and systems integration services to our customers through the following two segments of product and service offerings:

Broadband Infrastructure and Access; and

Professional Services.

Our Broadband Infrastructure and Access business provides network infrastructure products for wireline, cable and wireless communications network applications; Digital Subscriber Line (DSL) offerings for the telecommunications industry; and Internet Protocol (IP)-based offerings for the cable industry. These products consist of:

connectivity systems and components that provide the infrastructure to wireline, cable and wireless service providers to connect Internet, data, video and voice services to the network over copper, coaxial and fiber-optic cables, and

access systems used by wireline, cable and wireless service providers to deliver high-speed Internet, data and voice services to consumers and businesses in the last mile/kilometer of communications networks.

Professional Services

Professional services consist of systems integration services for broadband, multiservice communications over wireline, wireless, cable and enterprise networks. Professional services are used to plan, deploy and maintain communications networks that deliver Internet, data, video and voice services to consumers and businesses.

Our professional services are offered in North America and Europe and provide integration solutions for customers that deliver Internet, data, video and voice services over networks. Our professional services support both the multi-vendor and multi-service delivery requirements of our customers. These services support customers throughout the technology life-cycle, from network design, build-out, turn-up and testing to ongoing maintenance and training, and are utilized by our customers in creating and maintaining intra-office, inter-office, or coast-to-coast networks.

Manufacturing and Suppliers

We manufacture a variety of products that are fabricated, assembled and tested in our own facilities around the world. In an effort to reduce costs and improve customer service, we attempt to manufacture our products in the region of the world where they will be deployed. Our global sourcing team uses vendors from around the world to procure key components and raw material at advantageous prices and lead times. The manufacturing process for our electronic products consists primarily of assembly and testing of electronic systems built from fabricated parts, printed circuit boards and electronic components. The manufacturing process for our connectivity products is completely vertically integrated and consists primarily of the fabrication of jacks, plugs, cables and other basic components from raw materials as well as the assembly of components and the testing of products. Our sheet metal, plastic molding, stamping and machining capabilities permit us to configure components to customer specifications, provide competitive lead times and control production costs. We also utilize several outsourced manufacturing companies to manufacture, assemble and test certain of our products within our Broadband Infrastructure and Access segment.

We purchase raw materials and component parts from many suppliers. These purchases consist primarily of copper wire, optical fiber, steel, brass, nickel-steel alloys, gold, plastics, printed circuit boards, solid state components, discrete electronic components and similar items. Although many of these items are single-sourced, we have experienced no significant difficulties to date in obtaining adequate quantities. At this time, we are noticing some increase in the prices for some raw materials we use to make products. Such increases we believe are caused primarily by heightened demand for materials in developing markets such as China. To date, we have been able to mitigate most of such increases through greater purchasing power we now have following our acquisition of KRONE. These circumstances could change, however, and we cannot guarantee that sufficient quantities or quality of raw materials and component parts will be as readily available in the future or, if available, that we will be able to obtain them at favorable prices.

Competition

Competition in the communications equipment industry is intense, particularly in light of reduced spending levels by our customers. Many of our competitors have more extensive engineering, manufacturing, marketing, financial and personnel resources than we have. In addition, rapid technological developments within the communications industry have resulted in frequent changes among our group of competitors. Currently, our primary competitors include: For Broadband Infrastructure and Access products: 3M, ADTRAN, Andrew, CommScope, Corning, Furukawa, Nexans, Powerwave, Schmitt, Telect, and Tyco.

For Professional Services: Butler, Graniou, Greenwoods, Lucent Technologies, NEC, SAG, and SPIE.

We believe that our success in competing with other communications product manufacturers depends primarily on the following factors:

maintaining our brand recognition and reputation as a financially sound long-term supplier to our customers;

our engineering (research and development), manufacturing, sales and marketing skills;

the price, quality and reliability of our products; and

our delivery and service capabilities.



   Company Address: Biopôle Epalinges 1066
   Company Phone Number: 02 00   Stock Exchange / Ticker: NYSE ADCT
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Shares

GlobalTech Corporation's Common Stock Debuts on Over-the-Counter Market, Boosting Confidence and Driving Potential Growth

Published Tue, May 7 2024 9:00 AM UTC



GlobalTech Corporation is excited to announce that its common stock, denoted as GLTK on the OTC market, will now be available for trading. This landmark move is expected to have a significant impact on the company's shares, as investors and market participants eagerly anticipate the growth potential and future prospects of GlobalTech Corporation.
Fact 1: Global...

Shares

ADC Therapeutics Raises $105 Million in Offering and Incentivizes New Employees for Continued Success

Published Mon, May 6 2024 11:30 AM UTC

ADC Therapeutics SA Raises $105 Million in Underwritten Offering and Awards Stock Options to New Employees
Lausanne, Switzerland ?? May 6, 2024 ?? ADC Therapeutics SA (NYSE: ADCT), a leading biotechnology company focused on the development and commercialization of antibody drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors, announced ...

Clinical Study

ZYNLONTA Shows Promise as a Breakthrough Treatment for Relapsed/Refractory Marginal Zone Lymphoma: Initial Data Analysis Reveals Striking Clinical Outcomes

Published Mon, May 6 2024 10:00 AM UTC

CSIMarket.com is delighted to present groundbreaking findings from a Phase 2 clinical trial conducted by ADC Therapeutics. The trial investigates the efficacy of ZYNLONTA, a targeted antibody-drug conjugate (ADC), in patients suffering from relapsed/refractory marginal zone lymphoma (MZL). Initial data from 15 patients have shown impressive results, with remarkable complete...

Shares

ADC Therapeutics SA Continues Inducement Plan with Grants to New Employees, Impact on Shareholders Noteworthy

Published Wed, May 1 2024 8:05 PM UTC

ADC Therapeutics SA Announces Grants of Options to New Employees Under Inducement Plan
LAUSANNE, Switzerland, May 01, 2024 - ADC Therapeutics SA (NYSE: ADCT) has recently made grants of options to purchase an aggregate of 147,600 of the company's common shares to four new employees, as announced on May 1, 2024. These grants were offered as material inducement to the empl...

Clinical Study

ADC Therapeutics' Combination Therapy Shows Promising Results in Clinical Trial for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Treatment

Published Thu, Apr 4 2024 11:00 AM UTC

ADC Therapeutics, a biotechnology company specializing in the development of antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors, has recently provided updates on its ongoing LOTIS-7 clinical trial. This trial aims to evaluate the combination of ZYNLONTA (loncastuximab tesirine-lpyl) with either glofitamab or mosunetuzumab in pati...






 

Adc Therapeutics Sa's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Adc Therapeutics Sa does not provide revenue guidance.

Earnings Outlook
Adc Therapeutics Sa does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com